Related Experiment Videos

Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention

JAMA
|July 26, 1985
PubMed

Insights

Secondary Haemophilus influenzae type b disease spread in day-care centers is linked to age and hours spent in care. Rifampin prophylaxis effectively prevented secondary cases in close contacts.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Haemophilus influenzae type b (Hib) can cause serious secondary infections in day-care settings.
  • Understanding transmission dynamics is crucial for prevention strategies.

Purpose of the Study:

  • To identify risk factors for secondary Hib disease acquisition in day-care attendees.
  • To evaluate the effectiveness of rifampin prophylaxis in preventing secondary Hib infections.

Main Methods:

  • A cohort study was conducted across multiple locations (Seattle-King County, Atlanta, Oklahoma).
  • Identified primary Hib cases in children under 5 attending day-care.
  • Tracked secondary cases within the same classroom and center, analyzing age and attendance duration as risk factors.

Main Results:

  • 8% of primary Hib cases resulted in secondary infections within the same classroom.
  • Secondary disease risk was highest in infants (0-11 months) and decreased with age.
  • Increased hours per week in day-care correlated with higher transmission risk.
  • Rifampin prophylaxis demonstrated high efficacy (47%-100%) in preventing secondary Hib cases.

Conclusions:

  • Day-care attendance, particularly for younger children and longer durations, increases the risk of secondary Hib disease.
  • Rifampin is an effective chemoprophylactic agent for preventing Hib spread in day-care settings.

Related Concept Videos